Ratan R R, Murphy T H, Baraban J M
Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205.
J Neurosci. 1994 Jul;14(7):4385-92. doi: 10.1523/JNEUROSCI.14-07-04385.1994.
Although macromolecular synthesis inhibitors have been demonstrated to prevent neuronal apoptosis in a number of paradigms, their mechanisms of protection remains unclear. Recently, we found that neuronal death resulting from cystine deprivation, glutathione loss, and oxidative stress is apoptotic and is prevented by inhibitors of macromolecular synthesis. We now report that protection is associated with enhanced availability of acid-soluble cyst(e)ine and restoration of cellular glutathione levels. N-acetylcysteine, an agent that delivers exogenous cysteine intracellularly and raises glutathione, is also protective, while buthionine sulfoximine, an inhibitor of glutathione synthesis, prevents protection by inhibitors of macromolecular synthesis. These results suggest that protection provided by these agents, in this paradigm, derives from shunting of the amino acid cysteine from global protein synthesis into the formation of the antioxidant glutathione.
尽管在许多实验模型中已证明大分子合成抑制剂可预防神经元凋亡,但其保护机制仍不清楚。最近,我们发现,由胱氨酸剥夺、谷胱甘肽缺失和氧化应激导致的神经元死亡具有凋亡特征,并且可被大分子合成抑制剂所预防。我们现在报告,这种保护作用与酸溶性半胱氨酸(或胱氨酸)可用性的提高以及细胞谷胱甘肽水平的恢复有关。N-乙酰半胱氨酸是一种可将外源性半胱氨酸转运至细胞内并提高谷胱甘肽水平的药物,它也具有保护作用,而谷胱甘肽合成抑制剂丁硫氨酸亚砜胺则可阻止大分子合成抑制剂的保护作用。这些结果表明,在该实验模型中,这些药物所提供的保护作用源于将氨基酸半胱氨酸从整体蛋白质合成中分流出来,用于合成抗氧化剂谷胱甘肽。